⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332062 | 0.83 | CYP3A4 (0.37) | — | |
| SCHEMBL14846457 | 0.77 | — | — | |
| SCHEMBL14116674 | 0.73 | — | — | |
| SCHEMBL11138368 | 0.73 | — | — | |
| SCHEMBL3568523 | 0.73 | — | — | |
| SCHEMBL11438854 | 0.72 | CYP3A4 (0.38) | — | |
| SCHEMBL27274253 | 0.68 | DAO (0.41) | — | |
| SCHEMBL3045728 | 0.67 | RAB9A (0.42) | — | |
| SCHEMBL636568 | 0.65 | CYP3A4 (0.37) | — | |
| SCHEMBL21199727 | 0.65 | POLB (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240356074-A1 | NONAQUEOUS ELECTROLYTE BATTERY AND NONAQUEOUS ELECTROLYTE USED IN SAME | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-10-24 | — | — | US | claimed |
| EP-4398364-A1 | NONAQUEOUS ELECTROLYTE BATTERY AND NONAQUEOUS ELECTROLYTE USED IN SAME | Panasonic Intellectual Property Management Co., Ltd. (JP) | 2024-07-10 | — | — | EP | claimed |
| CN-117859228-A | Nonaqueous electrolyte battery and nonaqueous electrolyte used therefor | 松下知识产权经营株式会社 | 2024-04-09 | — | — | CN | claimed |
| WO-2023032799-A1 | NONAQUEOUS ELECTROLYTE BATTERY AND NONAQUEOUS ELECTROLYTE USED IN SAME | パナソニックＩＰマネジメント株式会社 | 2023-03-09 | — | — | WO | claimed |
| WO-2009021980-A1 | α-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-02-19 | — | — | WO | claimed |
| US-20240356074-A1 | NONAQUEOUS ELECTROLYTE BATTERY AND NONAQUEOUS ELECTROLYTE USED IN SAME | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-10-24 | — | — | US | disclosed |
| EP-4398364-A1 | NONAQUEOUS ELECTROLYTE BATTERY AND NONAQUEOUS ELECTROLYTE USED IN SAME | Panasonic Intellectual Property Management Co., Ltd. (JP) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023032799-A1 | NONAQUEOUS ELECTROLYTE BATTERY AND NONAQUEOUS ELECTROLYTE USED IN SAME | パナソニックＩＰマネジメント株式会社 | 2023-03-09 | — | — | WO | disclosed |
| US-20120149706-A1 | INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS | DUMAS JACQUES (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120149706-A1 | INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS | DUMAS JACQUES (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120129893-A1 | Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas | DUMAS JACQUES (US) | 2012-05-24 | — | — | US | disclosed |
| US-20120129893-A1 | Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas | DUMAS JACQUES (US) | 2012-05-24 | — | — | US | disclosed |
| WO-2003024967-A2 | INDOLIZINES AS KINASE PROTEIN INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2003-03-27 | — | — | WO | disclosed |
| EP-1047418-A4 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER AG (US) | 2001-02-07 | — | — | EP | disclosed |
| EP-1047418-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | Bayer Corporation (US) | 2000-11-02 | — | — | EP | disclosed |
| EP-1041982-A1 | INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS | Bayer Corporation (US) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999032106-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER CORPORATION (US) | 1999-07-01 | — | — | WO | disclosed |
| WO-1999032111-A1 | INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER CORPORATION (US) | 1999-07-01 | — | — | WO | disclosed |
| US-4230713-A | ANXIOLYTIC AGENTS | ICI AMERICAS INC. (US) | 1980-10-28 | — | — | US | disclosed |
| EP-0013817-A1 | 1-Imidazol-2-ylidene-3-thienyl-urea derivatives, processes therefor, and pharmaceutical compositions | ICI AMERICAS INC. (US) | 1980-08-06 | — | — | EP | disclosed |